July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Fundus autofluorescence risk factors for progression of geographic atrophy (GA) in the Age-Related Eye Disease Study 2
Author Affiliations & Notes
  • Jeong W Pak
    Ophthalmology and Visual Sciences, University of Wisconsin - Madison, Madison, Wisconsin, United States
  • Amitha Domalpally
    Ophthalmology and Visual Sciences, University of Wisconsin - Madison, Madison, Wisconsin, United States
  • Elvira Agron
    Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland, United States
  • Ronald P Danis
    Ophthalmology and Visual Sciences, University of Wisconsin - Madison, Madison, Wisconsin, United States
  • Traci E Clemons
    The EMMES Corporation, Rockville, Maryland, United States
  • Emily Y. Chew
    Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland, United States
  • Footnotes
    Commercial Relationships   Jeong Pak, None; Amitha Domalpally, None; Elvira Agron, None; Ronald Danis, EyeKor Inc (I), EyeKor Inc (E); Traci Clemons, None; Emily Chew, None
  • Footnotes
    Support  Research to Prevent Blindness
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2422. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jeong W Pak, Amitha Domalpally, Elvira Agron, Ronald P Danis, Traci E Clemons, Emily Y. Chew; Fundus autofluorescence risk factors for progression of geographic atrophy (GA) in the Age-Related Eye Disease Study 2. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2422.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To identify risk factors for progression of geographic atrophy (GA) from autofluoresence (AF) images in eyes with age-related macular degeneration (AMD)

Methods : AF images from the Age-Related Eye Disease Study 2 (AREDS2) ancillary study were centrally evaluated for presence and area of GA. The area of GA was measured using planimetry. In addition, area of abnormal AF surrounding GA (peri lesional) was also measured. Other AF variables evaluated include involvement of the center of macula, presence of halo and presence of background AF. Presence of GA was also confirmed on corresponding color photographs.

Results : AF images of 362 eyes from 340 participants with GA (decreased AF) with one or more years of followup were evaluated. The mean baseline area of GA from AF images was 3.5 mm2 (SD 5.2; median 1.2 mm2). The mean progression rate/year was 1.33 mm2 (SD 0.05) and on the square root scale 0.29 mm (SD 0.01). With multivariate analysis, baseline area of GA, duration (years from baseline), presence of background AF and peri lesional abnormal AF had significant correlation with progression rate for square root mm measurements and for the area scale (p<0.05). The presence of halo was a significant risk factor on the area scale (p=0.03) but not on the square root scale (p=0.23). Involvement of the center of macula showed no statistically significant association for GA progression.

Conclusions : Duration of GA, baseline area, presence of peri lesional abnormal AF and background AF are risk factors for GA enlargement on AF.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

An example of GA enlargement in the presence of AF risk factors

An example of GA enlargement in the presence of AF risk factors

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×